Diabetic Retinopathy: Mitochondria Caught in a Muddle of Homocysteine
Abstract
:1. Introduction
2. Mitochondria
3. Homocysteine
4. Homocysteine and Mitochondrial Damage
5. Homocysteine and Epigenetics
6. Strategies to Regulate Homocysteine and Protect Mitochondrial Damage
7. Conclusions
Funding
Acknowledgments
Conflicts of Interest
References
- Emerging Risk Factors, C.; Sarwar, N.; Gao, P.; Seshasai, S.R.; Gobin, R.; Kaptoge, S.; Di Angelantonio, E.; Ingelsson, E.; Lawlor, D.A.; Selvin, E.; et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet 2010, 375, 2215–2222. [Google Scholar] [CrossRef] [Green Version]
- Aiello, L.M. Perspectives on diabetic retinopathy. Am. J. Ophthalmol. 2003, 136, 122–135. [Google Scholar] [CrossRef]
- Zheng, Y.; He, M.; Congdon, N. The worldwide epidemic of diabetic retinopathy. Indian J. Ophthalmol. 2012, 60, 428–431. [Google Scholar]
- Fong, D.S.; Aiello, L.; Gardner, T.W.; King, G.L.; Blankenship, G.; Cavallerano, J.D.; Ferris, F.L., 3rd; Klein, R.; American Diabetes, A. Retinopathy in diabetes. Diabetes Care 2004, 27 (Suppl. 1), S84–S87. [Google Scholar] [CrossRef] [Green Version]
- Haritoglou, C.; Maier, M.; Neubauer, A.S.; Augustin, A.J. Current concepts of pharmacotherapy of diabetic macular edema. Exp. Opinion Pharmacoth. 2020, 21, 467–475. [Google Scholar] [CrossRef]
- Ting, D.S.; Cheung, G.C.; Wong, T.Y. Diabetic retinopathy: Global prevalence, major risk factors, screening practices and public health challenges: A review. Clin. Exp. Ophthalmol. 2016, 44, 260–277. [Google Scholar] [CrossRef] [Green Version]
- Srivastav, K.; Saxena, S.; Mahdi, A.A.; Shukla, R.K.; Meyer, C.H.; Akduman, L.; Khanna, V.K. Increased serum level of homocysteine correlates with retinal nerve fiber layer thinning in diabetic retinopathy. Mol. Vis. 2016, 22, 1352–1360. [Google Scholar]
- Malaguarnera, G.; Gagliano, C.; Giordano, M.; Salomone, S.; Vacante, M.; Bucolo, C.; Caraci, F.; Reibaldi, M.; Drago, F.; Avitabile, T.; et al. Homocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy. Biomed. Res. Int. 2014, 2014, 191497. [Google Scholar] [CrossRef]
- Tawfik, A.; Mohamed, R.; Elsherbiny, N.M.; DeAngelis, M.M.; Bartoli, M.; Al-Shabrawey, M. Homocysteine: A potential biomarker for diabetic retinopathy. J. Clin. Med. 2019, 8, 121. [Google Scholar] [CrossRef] [Green Version]
- Maron, B.A.; Loscalzo, J. The treatment of hyperhomocysteinemia. Ann. Rev. Med. 2009, 60, 39–54. [Google Scholar] [CrossRef] [Green Version]
- Minniti, G.; Calevo, M.G.; Giannattasio, A.; Camicione, P.; Armani, U.; Lorini, R.; Piana, G. Plasma homocysteine in patients with retinal vein occlusion. Eur. J. Ophthalmol. 2014, 24, 735–743. [Google Scholar] [CrossRef] [PubMed]
- Kundi, H.; Kiziltunc, E.; Ates, I.; Cetin, M.; Barca, A.N.; Ozkayar, N.; Ornek, E. Association between plasma homocysteine levels and end-organ damage in newly diagnosed type 2 diabetes mellitus patients. Endocr. Res. 2017, 42, 36–41. [Google Scholar] [CrossRef] [PubMed]
- Ibrahim, A.S.; Mander, S.; Hussein, K.A.; Elsherbiny, N.M.; Smith, S.B.; Al-Shabrawey, M.; Tawfik, A. Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration. Oncotarget 2016, 7, 8532–8545. [Google Scholar] [CrossRef] [PubMed]
- Van Guldener, C.; Stehouwer, C.D. Diabetes mellitus and hyperhomocysteinemia. Sem. Vasc. Med. 2002, 2, 87–95. [Google Scholar] [CrossRef] [PubMed]
- Mohammad, G.; Kowluru, R.A. Homocysteine disrupts balance between mmp-9 and its tissue inhibitor in diabetic retinopathy: The role of DNA methylation. Int. J. Mol. Sci. 2020, 21, 1771. [Google Scholar] [CrossRef] [Green Version]
- Brazionis, L.; Rowley, K., Sr.; Itsiopoulos, C.; Harper, C.A.; O’Dea, K. Homocysteine and diabetic retinopathy. Diabetes Care 2008, 31, 50–56. [Google Scholar] [CrossRef] [Green Version]
- Bulum, T.; Blaslov, K.; Duvnjak, L. Plasma homocysteine is associated with retinopathy in type 1 diabetic patients in the absence of nephropathy. Semin. Ophthalmol. 2016, 31, 198–202. [Google Scholar] [CrossRef]
- Feng, Y.; Shan, M.Q.; Bo, L.; Zhang, X.Y.; Hu, J. Association of homocysteine with type 1 diabetes mellitus: A meta-analysis. Int. J. Clin. Exp. Med. 2015, 8, 12529–12538. [Google Scholar]
- Xu, C.; Wu, Y.; Liu, G.; Liu, X.; Wang, F.; Yu, J. Relationship between homocysteine level and diabetic retinopathy: A systematic review and meta-analysis. Diag. Pathol. 2014, 9, 167. [Google Scholar] [CrossRef] [Green Version]
- Lei, X.; Zeng, G.; Zhang, Y.; Li, Q.; Zhang, J.; Bai, Z.; Yang, K. Association between homocysteine level and the risk of diabetic retinopathy: A systematic review and meta-analysis. Diabetol. Metab. Syndr. 2018, 10, 61. [Google Scholar] [CrossRef]
- Dong, N.; Shi, H.; Tang, X. Plasma homocysteine levels are associated with macular thickness in type 2 diabetes without diabetic macular edema. Int. Ophthalmol. 2018, 38, 737–746. [Google Scholar] [CrossRef] [PubMed]
- Kowluru, R.A.; Mohammad, G.; Sahajpal, N. Faulty homocysteine recycling in diabetic retinopathy. Eye Vision 2020, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Frank, R.N. Diabetic retinopathy. N. Engl. J. Med. 2004, 350, 48–58. [Google Scholar] [CrossRef] [PubMed]
- Kowluru, R.A.; Kowluru, A.; Mishra, M.; Kumar, B. Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy. Prog. Retin. Eye Res. 2015, 48, 40–61. [Google Scholar] [CrossRef]
- Kowluru, R.A.; Mishra, M. Oxidative stress, mitochondrial damage and diabetic retinopathy. Biochim. Biophys. Acta 2015, 1852, 2474–2483. [Google Scholar] [CrossRef] [Green Version]
- Kanwar, M.; Chan, P.S.; Kern, T.S.; Kowluru, R.A. Oxidative damage in the retinal mitochondria of diabetic mice: Possible protection by superoxide dismutase. Investig. Ophthalmol. Vis. Sci. 2007, 48, 3805–3811. [Google Scholar] [CrossRef] [Green Version]
- Ferrington, D.A.; Fisher, C.R.; Kowluru, R.A. Mitochondrial defects drive degenerative retinal diseases. Trends Mol. Med. 2020, 26, 105–118. [Google Scholar] [CrossRef]
- Duraisamy, A.J.; Mohammad, G.; Kowluru, R.A. Mitochondrial fusion and maintenance of mitochondrial homeostasis in diabetic retinopathy. Biochim. Biophys. Acta Mol. Basis Dis. 2019, 1865, 1617–1626. [Google Scholar] [CrossRef]
- Sahajpal, N.; Kowluru, A.; Kowluru, R.A. The regulatory role of rac1, a small molecular weight gtpase, in the development of diabetic retinopathy. J. Clin. Med. 2019, 8, 965. [Google Scholar] [CrossRef] [Green Version]
- Kowluru, R.A.; Mishra, M. Regulation of matrix metalloproteinase in the pathogenesis of diabetic retinopathy. Prog. Mol. Biol. Transl. Sci. 2017, 148, 67–85. [Google Scholar]
- Mohammad, G.; Kowluru, R.A. Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab. Investig. 2010, 90, 1365–1372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Beard, R.S., Jr.; Bearden, S.E. Vascular complications of cystathionine beta-synthase deficiency: Future directions for homocysteine-to-hydrogen sulfide research. Am. J. Physiol. Heart Circul. Physiol. 2011, 300, H13–H26. [Google Scholar] [CrossRef] [PubMed]
- Weber, G.J.; Pushpakumar, S.; Tyagi, S.C.; Sen, U. Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension. Pharmacol. Res. 2016, 113, 300–312. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shu, X.J.; Li, Z.F.; Chang, Y.W.; Liu, S.Y.; Wang, W.H. Effects of folic acid combined with vitamin b12 on dvt in patients with homocysteine cerebral infarction. Eur. Rev. Med. Pharmacol. Sci. 2017, 21, 2538–2544. [Google Scholar]
- Bozic-Mijovski, M. Hyperhomocysteinemia and thrombophilia. Clin. Chem. Lab. Med. 2010, 48 (Suppl. 1), S89–S95. [Google Scholar] [CrossRef]
- Cheng, Z.; Shen, X.; Jiang, X.; Shan, H.; Cimini, M.; Fang, P.; Ji, Y.; Park, J.Y.; Drosatos, K.; Yang, X.; et al. Hyperhomocysteinemia potentiates diabetes-impaired edhf-induced vascular relaxation: Role of insufficient hydrogen sulfide. Redox Biol. 2018, 16, 215–225. [Google Scholar] [CrossRef]
- Kamat, P.K.; Kalani, A.; Tyagi, S.C.; Tyagi, N. Hydrogen sulfide epigenetically attenuates homocysteine-induced mitochondrial toxicity mediated through nmda receptor in mouse brain endothelial (bend3) cells. J. Cell Physiol. 2015, 230, 378–394. [Google Scholar] [CrossRef] [Green Version]
- Shefa, U.; Kim, M.S.; Jeong, N.Y.; Jung, J. Antioxidant and cell-signaling functions of hydrogen sulfide in the central nervous system. Oxid Med. Cell Long 2018, 2018, 1873962. [Google Scholar] [CrossRef]
- Karmin, O.; Siow, Y.L. Metabolic imbalance of homocysteine and hydrogen sulfide in kidney disease. Curr. Med. Chem. 2018, 25, 367–377. [Google Scholar]
- Lu, S.C. Glutathione synthesis. Biochim. Biophys. Acta 2013, 1830, 3143–3153. [Google Scholar] [CrossRef] [Green Version]
- Mujumdar, V.S.; Aru, G.M.; Tyagi, S.C. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J. Cell Biochem. 2001, 82, 491–500. [Google Scholar] [CrossRef] [PubMed]
- Elsherbiny, N.M.; Sharma, I.; Kira, D.; Alhusban, S.; Samra, Y.A.; Jadeja, R.; Martin, P.; Al-Shabrawey, M.; Tawfik, A. Homocysteine induces inflammation in retina and brain. Biomolecules 2020, 10, 393. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maeda, M.; Yamamoto, I.; Fukuda, M.; Motomura, T.; Nishida, M.; Nonen, S.; Fujio, Y.; Kasayama, S.; Azuma, J. Mthfr gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in japanese type 2 diabetic patients. J. Diab. Compl. 2008, 22, 119–125. [Google Scholar] [CrossRef] [PubMed]
- Kowluru, R.A.; Kowluru, A.; Veluthakal, R.; Mohammad, G.; Syed, I.; Santos, J.M.; Mishra, M. Tiam1-rac1 signalling axis-mediated activation of nadph oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy. Diabetologia 2014, 57, 1047–1056. [Google Scholar] [CrossRef] [PubMed]
- Okamoto, T.; Akuta, T.; Tamura, F.; van Der Vliet, A.; Akaike, T. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol. Chem. 2004, 385, 997–1006. [Google Scholar] [CrossRef] [PubMed]
- Tyagi, S.C.; Rodriguez, W.; Patel, A.; Roberts, A.M.; Falcone, J.C.; Passmore, J.C.; Fleming, J.T.; Joshua, I.G. Hyperhomocysteinemic diabetic cardiomyopathy: Oxidative stress, remodeling, and endothelial-myocyte uncoupling. J. Card. Pharmacol. Ther. 2005, 10, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Givvimani, S.; Kundu, S.; Pushpakumar, S.; Doyle, V.; Narayanan, N.; Winchester, L.J.; Veeranki, S.; Metreveli, N.; Tyagi, S.C. Hyperhomocysteinemia: A missing link to dysfunctional hdl via paraoxanase-1. Canad. J. Physiol. Pharmacol. 2015, 93, 755–763. [Google Scholar] [CrossRef]
- Vacek, T.P.; Qipshidze, N.; Tyagi, S.C. Hydrogen sulfide and sodium nitroprusside compete to activate/deactivate mmps in bone tissue homogenates. Vas. Health Risk Manag. 2013, 9, 117–123. [Google Scholar]
- Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 2003, 17, 24–38. [Google Scholar] [CrossRef]
- Mishra, M.; Zhong, Q.; Kowluru, R.A. Epigenetic modifications of nrf2-mediated glutamate-cysteine ligase: Implications for the development of diabetic retinopathy and the metabolic memory phenomenon associated with its continued progression. Free Rad. Biol. Med. 2014, 75, 129–139. [Google Scholar] [CrossRef]
- Kowluru, R.A.; Mishra, M. Epigenetic regulation of redox signaling in diabetic retinopathy: Role of nrf2. Free Rad. Biol. Med. 2017, 103, 155–164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mani, M.; Khaghani, S.; Gol Mohammadi, T.; Zamani, Z.; Azadmanesh, K.; Meshkani, R.; Pasalar, P.; Mostafavi, E. Activation of nrf2-antioxidant response element mediated glutamate cysteine ligase expression in hepatoma cell line by homocysteine. Hepat. Month. 2013, 13, e8394. [Google Scholar] [CrossRef] [PubMed]
- Elanchezhian, R.; Palsamy, P.; Madson, C.J.; Lynch, D.W.; Shinohara, T. Age-related cataracts: Homocysteine coupled endoplasmic reticulum stress and suppression of nrf2-dependent antioxidant protection. Chemico Biol. Inter. 2012, 200, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Navneet, S.; Zhao, J.; Wang, J.; Mysona, B.; Barwick, S.; Ammal Kaidery, N.; Saul, A.; Kaddour-Djebbar, I.; Bollag, W.B.; Thomas, B.; et al. Hyperhomocysteinemia-induced death of retinal ganglion cells: The role of muller glial cells and nrf2. Redox Biol. 2019, 24, 101199. [Google Scholar] [CrossRef] [PubMed]
- Zhong, Q.; Mishra, M.; Kowluru, R.A. Transcription factor nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2013, 54, 3941–3948. [Google Scholar] [CrossRef]
- Sebastian, D.; Palacin, M.; Zorzano, A. Mitochondrial dynamics: Coupling mitochondrial fitness with healthy aging. Trends Mol. Med. 2017, 23, 201–215. [Google Scholar] [CrossRef]
- Stuppia, G.; Rizzo, F.; Riboldi, G.; Del Bo, R.; Nizzardo, M.; Simone, C.; Comi, G.P.; Bresolin, N.; Corti, S. Mfn2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives. J. Neurol. Sci. 2015, 356, 7–18. [Google Scholar] [CrossRef]
- Imai, Y.; Lu, B. Mitochondrial dynamics and mitophagy in parkinson’s disease: Disordered cellular power plant becomes a big deal in a major movement disorder. Curr. Opin. Neurobiol. 2011, 21, 935–941. [Google Scholar] [CrossRef] [Green Version]
- Twig, G.; Shirihai, O.S. The interplay between mitochondrial dynamics and mitophagy. Antiox. Redox Signal. 2011, 14, 1939–1951. [Google Scholar] [CrossRef] [Green Version]
- Devi, T.S.; Somayajulu, M.; Kowluru, R.A.; Singh, L.P. Txnip regulates mitophagy in retinal muller cells under high-glucose conditions: Implications for diabetic retinopathy. Cell Death Dis. 2017, 8, e2777. [Google Scholar] [CrossRef]
- Timkova, V.; Tatarkova, Z.; Lehotsky, J.; Racay, P.; Dobrota, D.; Kaplan, P. Effects of mild hyperhomocysteinemia on electron transport chain complexes, oxidative stress, and protein expression in rat cardiac mitochondria. Mol. Cell Biochem. 2016, 411, 261–270. [Google Scholar] [CrossRef]
- Zhang, Z.; Wei, C.; Zhou, Y.; Yan, T.; Wang, Z.; Li, W.; Zhao, L. Homocysteine induces apoptosis of human umbilical vein endothelial cells via mitochondrial dysfunction and endoplasmic reticulum stress. Oxid. Med. Cell. Long. 2017, 2017, 5736506. [Google Scholar] [CrossRef]
- Mizutani, M.; Kern, T.S.; Lorenzi, M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Investig. 1996, 97, 2883–2890. [Google Scholar] [CrossRef]
- Familtseva, A.; Kalani, A.; Chaturvedi, P.; Tyagi, N.; Metreveli, N.; Tyagi, S.C. Mitochondrial mitophagy in mesenteric artery remodeling in hyperhomocysteinemia. Physiol. Rep. 2014, 2, e00283. [Google Scholar] [CrossRef]
- Ganapathy, P.S.; Perry, R.L.; Tawfik, A.; Smith, R.M.; Perry, E.; Roon, P.; Bozard, B.R.; Ha, Y.; Smith, S.B. Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells. Investig. Ophthalmol. Vis. Sci. 2011, 52, 5551–5558. [Google Scholar] [CrossRef]
- Wallace, D.C.; Chalkia, D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb. Perspect. Biol. 2013, 5, a021220. [Google Scholar] [CrossRef]
- Kowluru, R.A.; Mohammad, G. Epigenetics and mitochondrial stability in the metabolic memory phenomenon associated with continued progression of diabetic retinopathy. Sci. Rep. 2020, 10, 6655. [Google Scholar] [CrossRef] [Green Version]
- Jarrett, S.G.; Lin, H.; Godley, B.F.; Boulton, M.E. Mitochondrial DNA damage and its potential role in retinal degeneration. Prog. Retin. Eye Res. 2008, 27, 596–607. [Google Scholar] [CrossRef]
- Santos, R.X.; Correia, S.C.; Zhu, X.; Smith, M.A.; Moreira, P.I.; Castellani, R.J.; Nunomura, A.; Perry, G. Mitochondrial DNA oxidative damage and repair in aging and alzheimer’s disease. Antiox. Redox Signal. 2013, 18, 2444–2457. [Google Scholar] [CrossRef]
- Kowluru, R.A. Mitochondrial stability in diabetic retinopathy: Lessons learned from epigenetics. Diabetes 2019, 68, 241–247. [Google Scholar] [CrossRef] [Green Version]
- Madsen-Bouterse, S.A.; Mohammad, G.; Kanwar, M.; Kowluru, R.A. Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression. Antiox. Redox Signal. 2010, 13, 797–805. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mishra, M.; Kowluru, R.A. Retinal mitochondrial DNA mismatch repair in the development of diabetic retinopathy, and its continued progression after termination of hyperglycemia. Investig. Ophthalmol. Vis. Sci. 2014, 55, 6960–6967. [Google Scholar] [CrossRef] [PubMed]
- Veeranki, S.; Winchester, L.J.; Tyagi, S.C. Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications. Biochim. Biophys. Acta 2015, 1852, 732–741. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Santos, J.M.; Tewari, S.; Goldberg, A.F.X.; Kowluru, R.A. Mitochondria biogenesis and the development of diabetic retinopathy. Free Rad. Biol. Med. 2011, 51, 1849–1860. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Szyf, M.; Meaney, M.J. Epigenetics, behaviour, and health. Allergy Asthma Clin. Immunol. 2008, 4, 37–49. [Google Scholar] [CrossRef] [Green Version]
- Ling, C.; Groop, L. Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes 2009, 58, 2718–2725. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moosavi, A.; Motevalizadeh Ardekani, A. Role of epigenetics in biology and human diseases. Iran. Biomed. J. 2016, 20, 246–258. [Google Scholar]
- Alelu-Paz, R.; Ashour, N.; Gonzalez-Corpas, A.; Ropero, S. DNA methylation, histone modifications, and signal transduction pathways: A close relationship in malignant gliomas pathophysiology. J. Signal. Transd. 2012, 2012, 956958. [Google Scholar] [CrossRef]
- Elmasry, K.; Mohamed, R.; Sharma, I.; Elsherbiny, N.M.; Liu, Y.; Al-Shabrawey, M.; Tawfik, A. Epigenetic modifications in hyperhomocysteinemia: Potential role in diabetic retinopathy and age-related macular degeneration. Oncotarget 2018, 9, 12562–12590. [Google Scholar] [CrossRef] [Green Version]
- Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993, 329, 977–986. [Google Scholar] [CrossRef]
- Tian, H.; Tian, D.; Zhang, C.; Wang, W.; Wang, L.; Ge, M.; Hou, Q.; Zhang, W. Efficacy of folic acid therapy in patients with hyperhomocysteinemia. J. Am. Coll. Nutr. 2017, 36, 528–532. [Google Scholar] [CrossRef] [PubMed]
- Nigwekar, S.U.; Kang, A.; Zoungas, S.; Cass, A.; Gallagher, M.P.; Kulshrestha, S.; Navaneethan, S.D.; Perkovic, V.; Strippoli, G.F.; Jardine, M.J. Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database Syst. Rev. 2016. [Google Scholar] [CrossRef] [PubMed]
- Suzuki, K.; Sagara, M.; Aoki, C.; Tanaka, S.; Aso, Y. Clinical implication of plasma hydrogen sulfide levels in japanese patients with type 2 diabetes. Intern. Med. 2017, 56, 17–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tyagi, N.; Moshal, K.S.; Sen, U.; Vacek, T.P.; Kumar, M.; Hughes, W.M., Jr.; Kundu, S.; Tyagi, S.C. H2s protects against methionine-induced oxidative stress in brain endothelial cells. Antiox. Redox Signal. 2009, 11, 25–33. [Google Scholar] [CrossRef] [Green Version]
- Narne, P.; Pandey, V.; Phanithi, P.B. Role of nitric oxide and hydrogen sulfide in ischemic stroke and the emergent epigenetic underpinnings. Mol. Neurobiol. 2019, 56, 1749–1769. [Google Scholar] [CrossRef]
- Qian, L.L.; Liu, X.Y.; Chai, Q.; Wang, R.X. Hydrogen sulfide in diabetic complications: Focus on molecular mechanisms. Endoc. Metab. Dis. Drugs Targets 2018. [Google Scholar] [CrossRef]
- Zaorska, E.; Tomasova, L.; Koszelewski, D.; Ostaszewski, R.; Ufnal, M. Hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors. Biomolecules 2020, 10, 323. [Google Scholar] [CrossRef] [Green Version]
- Yang, C.T.; Chen, L.; Xu, S.; Day, J.J.; Li, X.; Xian, M. Recent development of hydrogen sulfide releasing/stimulating reagents and their potential applications in cancer and glycometabolic disorders. Front. Pharmacol. 2017, 8, 664. [Google Scholar] [CrossRef] [Green Version]
- Powell, C.R.; Dillon, K.M.; Matson, J.B. A review of hydrogen sulfide (h2s) donors: Chemistry and potential therapeutic applications. Biochem. Pharmacol. 2018, 149, 110–123. [Google Scholar] [CrossRef]
© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kowluru, R.A. Diabetic Retinopathy: Mitochondria Caught in a Muddle of Homocysteine. J. Clin. Med. 2020, 9, 3019. https://doi.org/10.3390/jcm9093019
Kowluru RA. Diabetic Retinopathy: Mitochondria Caught in a Muddle of Homocysteine. Journal of Clinical Medicine. 2020; 9(9):3019. https://doi.org/10.3390/jcm9093019
Chicago/Turabian StyleKowluru, Renu A. 2020. "Diabetic Retinopathy: Mitochondria Caught in a Muddle of Homocysteine" Journal of Clinical Medicine 9, no. 9: 3019. https://doi.org/10.3390/jcm9093019